Novartis AG Stock price

Equities

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange 11:30:49 2023-12-07 am EST Intraday chart for Novartis AG 5-day change 1st Jan Change
84.25 CHF -0.75% -1.02% +0.79%
Sales 2023 * 46.23B 40.48B Sales 2024 * 47.51B 41.6B Capitalization 200B 175B
Net income 2023 * 9.82B 8.6B Net income 2024 * 10.29B 9.01B EV / Sales 2023 *
4,59x
Net Debt 2023 * 12.84B 11.25B Net Debt 2024 * 12.39B 10.85B EV / Sales 2024 *
4,46x
P/E ratio 2023 *
18,8x
P/E ratio 2024 *
17,9x
Employees 101,703
Yield 2023 *
3,64%
Yield 2024 *
3,80%
Free-Float 86.85%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.70%
1 week-1.02%
Current month-1.02%
1 month+0.08%
3 months-4.94%
6 months-5.87%
Current year+0.79%
More quotes
1 week
83.90
Extreme 83.9
86.41
1 month
83.09
Extreme 83.09
86.79
Current year
73.74
Extreme 73.74
94.77
1 year
73.74
Extreme 73.74
94.77
3 years
72.84
Extreme 72.84
94.77
5 years
65.09
Extreme 65.09
96.38
10 years
65.09
Extreme 65.09
103.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 47 2004
Director of Finance/CFO 58 2002
Chief Tech/Sci/R&D Officer 61 2022
Members of the board TitleAgeSince
Director/Board Member 61 2012
Director/Board Member 64 2020
Chairman 67 2012
More insiders
Date Price Change Volume
23-12-07 84.25 -0.75% 2 474 198
23-12-06 84.89 -0.20% 3,666,617
23-12-05 85.06 -1.25% 3,492,673
23-12-04 86.14 +0.89% 2,761,427
23-12-01 85.38 +0.31% 2,277,071

Delayed Quote Swiss Exchange, December 07, 2023 at 11:30 am EST

More quotes
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical products (81.7%): used to treat cardiovascular, respiratory, and dermatological diseases, gastrointestinal disorders, cancers, central nervous system disorders, hormone imbalances, etc.; - generic drugs (18.3%; Sandoz). Net sales are distributed geographically as follows: Europe (36.5%), the United States (34.9%), Asia/Africa/Australasia (20.9%), Canada and Latin America (7.7%).
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
97.09USD
Average target price
105.75USD
Spread / Average Target
+8.92%
Consensus
1st Jan change Capi.
+0.79% 200 B $
+59.98% 530 B $
+42.05% 438 B $
-11.74% 377 B $
-5.69% 268 B $
-8.46% 258 B $
-14.13% 230 B $
-9.98% 198 B $
-43.93% 163 B $
+3.69% 144 B $
Other Pharmaceuticals
  1. Stock
  2. Equities
  3. Stock Novartis AG - Swiss Exchange
Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer